BioMarin To Present Positive VOXZOGO (Vosoritide) Data From CANOPY Clinical Program At 2024 International Skeletal Dysplasia Society Meeting
$1000 Invested In Novavax 5 Years Ago Would Be Worth This Much Today
GE Vernova To Rally Over 30%? Here Are 10 Top Analyst Forecasts For Tuesday
Biomarin Pharmaceutical Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Regeneron Pharmaceuticals, Maintains $1015 Price Target
Regeneron Pharmaceuticals Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Neurocrine Biosciences, Maintains $155 Price Target
Neurocrine Biosciences Analyst Ratings
DeSantis Administration Cautions Against Pfizer, Moderna MRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
Court Finds United Therapeutics' Interference With Launch of Generic Treprostinil Injection Caused Losses Of More Than $137M
Don't just focus on the polls! The trend of the US stock market is the compass for the US presidential election. Here is an investment guide for you to check out.
Analysts have found that since 1984, as long as the S&P 500 index rises accumulatively between August and October, the ruling party will win the election; on the contrary, if the S&P 500 index drops during this period, the challenger will win.
Do Queasy Side Effects Mean the End of Weight-loss Drug Stock Hype?
"Florida Discourages Use Of MRNA Covid Vaccines In Older Adults; In Updated Guidance To Health Care Providers, Florida Health Officials Advise That "Non-mRNA Covid-19 Vaccines And Treatment" Should Be Prioritized" - NBC News
Novavax Shares Are Trading Higher After the Company Announced Doses of Its 2024-2025 Formula COVID-19 Vaccine Are Now Available at Thousands of Locations Nationwide.
Regeneron Pharmaceuticals And Sanofi Announce FDA Approval For Dupixent In The U.S. As First And Only Treatment For Adolescents With Chronic Rhinosinusitis With Nasal Polyps
Kiniksa Draws Buy at Jefferies on Potential Blockbuster Status for Lead Drug
Novavax COVID-19 Vaccines Now Available
Neurocrine Ending Development of Luvadaxistat Amid Failed Study
Jones Research Starts Larimar at Buy, Cites Lead Asset Nomlabofusp
Why Are Novavax Shares Trading Lower Today?